188 related articles for article (PubMed ID: 29258825)
1. Role of diffusion-weighted MR imaging in predicting the grade of nonfunctional pancreatic neuroendocrine tumors.
Kulali F; Semiz-Oysu A; Demir M; Segmen-Yilmaz M; Bukte Y
Diagn Interv Imaging; 2018 May; 99(5):301-309. PubMed ID: 29258825
[TBL] [Abstract][Full Text] [Related]
2. Computed tomography and magnetic resonance imaging features of lipid-rich neuroendocrine tumors of the pancreas.
Fukukura Y; Shindo T; Higashi M; Takumi K; Umanodan T; Yoneyama T; Yoshiura T
World J Gastroenterol; 2015 Sep; 21(34):10008-17. PubMed ID: 26379406
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic neuroendocrine neoplasms at magnetic resonance imaging: comparison between grade 3 and grade 1/2 tumors.
Guo C; Chen X; Xiao W; Wang Q; Sun K; Wang Z
Onco Targets Ther; 2017; 10():1465-1474. PubMed ID: 28331340
[TBL] [Abstract][Full Text] [Related]
4. Is the combination of MR and CT findings useful in determining the tumor grade of pancreatic neuroendocrine tumors?
Toshima F; Inoue D; Komori T; Yoshida K; Yoneda N; Minami T; Matsui O; Ikeda H; Gabata T
Jpn J Radiol; 2017 May; 35(5):242-253. PubMed ID: 28258323
[TBL] [Abstract][Full Text] [Related]
5. Value of diffusion-weighted magnetic resonance imaging in predicting World Health Organization grade in G1/G2 pancreatic neuroendocrine tumors.
Guo C; Zhuge X; Chen X; Wang Z; Xiao W; Wang Q
Oncol Lett; 2017 Jun; 13(6):4141-4146. PubMed ID: 28599415
[TBL] [Abstract][Full Text] [Related]
6. The value of gadoxetic acid-enhanced and diffusion-weighted MRI for prediction of grading of pancreatic neuroendocrine tumors.
Jang KM; Kim SH; Lee SJ; Choi D
Acta Radiol; 2014 Mar; 55(2):140-8. PubMed ID: 23897307
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic neuroendocrine neoplasms: Magnetic resonance imaging features according to grade and stage.
De Robertis R; Cingarlini S; Tinazzi Martini P; Ortolani S; Butturini G; Landoni L; Regi P; Girelli R; Capelli P; Gobbo S; Tortora G; Scarpa A; Pederzoli P; D'Onofrio M
World J Gastroenterol; 2017 Jan; 23(2):275-285. PubMed ID: 28127201
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the Added Value of Diffusion-Weighted Imaging to Conventional Magnetic Resonance Imaging in Pancreatic Neuroendocrine Tumors and Comparison With 68Ga-DOTANOC Positron Emission Tomography/Computed Tomography.
Farchione A; Rufini V; Brizi MG; Iacovazzo D; Larghi A; Massara RM; Petrone G; Poscia A; Treglia G; De Marinis L; Giordano A; Rindi G; Bonomo L
Pancreas; 2016 Mar; 45(3):345-54. PubMed ID: 26418904
[TBL] [Abstract][Full Text] [Related]
9. Prediction of pancreatic neuroendocrine tumour grade with MR imaging features: added value of diffusion-weighted imaging.
Lotfalizadeh E; Ronot M; Wagner M; Cros J; Couvelard A; Vullierme MP; Allaham W; Hentic O; Ruzniewski P; Vilgrain V
Eur Radiol; 2017 Apr; 27(4):1748-1759. PubMed ID: 27543074
[TBL] [Abstract][Full Text] [Related]
10. Can diffusion-weighted magnetic resonance imaging of clear cell renal carcinoma predict low from high nuclear grade tumors.
Parada Villavicencio C; Mc Carthy RJ; Miller FH
Abdom Radiol (NY); 2017 Apr; 42(4):1241-1249. PubMed ID: 27904923
[TBL] [Abstract][Full Text] [Related]
11. Contrast-enhanced dynamic and diffusion-weighted MR imaging at 3.0T to assess aggressiveness of bladder cancer.
Zhou G; Chen X; Zhang J; Zhu J; Zong G; Wang Z
Eur J Radiol; 2014 Nov; 83(11):2013-8. PubMed ID: 25213829
[TBL] [Abstract][Full Text] [Related]
12. Neuroendocrine liver metastases: Value of apparent diffusion coefficient and enhancement ratios for characterization of histopathologic grade.
Besa C; Ward S; Cui Y; Jajamovich G; Kim M; Taouli B
J Magn Reson Imaging; 2016 Dec; 44(6):1432-1441. PubMed ID: 27227756
[TBL] [Abstract][Full Text] [Related]
13. Exploratory Study of Apparent Diffusion Coefficient Histogram Metrics in Assessing Pancreatic Malignancy.
Taffel MT; Luk L; Ream JM; Rosenkrantz AB
Can Assoc Radiol J; 2019 Nov; 70(4):416-423. PubMed ID: 31604596
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic neuroendocrine tumour: Correlation of apparent diffusion coefficient or WHO classification with recurrence-free survival.
Kim M; Kang TW; Kim YK; Kim SH; Kwon W; Ha SY; Ji SA
Eur J Radiol; 2016 Mar; 85(3):680-7. PubMed ID: 26826888
[TBL] [Abstract][Full Text] [Related]
15. Grade 2 pancreatic neuroendocrine tumors: overbroad scope of Ki-67 index according to MRI features.
Hu Y; Rao S; Xu X; Tang Y; Zeng M
Abdom Radiol (NY); 2018 Nov; 43(11):3016-3024. PubMed ID: 29619528
[TBL] [Abstract][Full Text] [Related]
16. Intravoxel incoherent motion diffusion-weighted imaging of pancreatic neuroendocrine tumors: prediction of the histologic grade using pure diffusion coefficient and tumor size.
Hwang EJ; Lee JM; Yoon JH; Kim JH; Han JK; Choi BI; Lee KB; Jang JY; Kim SW; Nickel MD; Kiefer B
Invest Radiol; 2014 Jun; 49(6):396-402. PubMed ID: 24500090
[TBL] [Abstract][Full Text] [Related]
17. The high-grade (WHO G3) pancreatic neuroendocrine tumor category is morphologically and biologically heterogenous and includes both well differentiated and poorly differentiated neoplasms.
Basturk O; Yang Z; Tang LH; Hruban RH; Adsay V; McCall CM; Krasinskas AM; Jang KT; Frankel WL; Balci S; Sigel C; Klimstra DS
Am J Surg Pathol; 2015 May; 39(5):683-90. PubMed ID: 25723112
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic neuroendocrine tumor: Correlations between MRI features, tumor biology, and clinical outcome after surgery.
Canellas R; Lo G; Bhowmik S; Ferrone C; Sahani D
J Magn Reson Imaging; 2018 Feb; 47(2):425-432. PubMed ID: 28480609
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic neuroendocrine tumors: Correlation between the contrast-enhanced computed tomography features and the pathological tumor grade.
Takumi K; Fukukura Y; Higashi M; Ideue J; Umanodan T; Hakamada H; Kanetsuki I; Yoshiura T
Eur J Radiol; 2015 Aug; 84(8):1436-1443. PubMed ID: 26022520
[TBL] [Abstract][Full Text] [Related]
20. Pattern and clinical predictors of lymph node involvement in nonfunctioning pancreatic neuroendocrine tumors (NF-PanNETs).
Partelli S; Gaujoux S; Boninsegna L; Cherif R; Crippa S; Couvelard A; Scarpa A; Ruszniewski P; Sauvanet A; Falconi M
JAMA Surg; 2013 Oct; 148(10):932-9. PubMed ID: 23986355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
